Evidence map›Paper›PMID 37509118›Full record

ArticleBiomolecules2023

Syntheses of 25-Adamantyl-25-alkyl-2-methylidene-1α,25-dihydroxyvitamin D

Kazuki Maekawa, Michiyasu Ishizawa, Takashi Ikawa, Hironao Sajiki, Taro Matsumoto, Hiroaki Tokiwa, Makoto Makishima, Sachiko Yamada

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kazuki MaekawaDepartment of Chemistry, Faculty of Science, Rikkyo University, Toshima-ku, Tokyo 171-8501, Japan.
Michiyasu IshizawaDivision of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Itabashi-ku, Tokyo 173-8610, Japan.
Takashi IkawaLaboratory of Organic Chemistry, Gifu Pharmaceutical University 1-25-4 Daigaku-Nishi, Gifu 501-1196, Japan.
Hironao SajikiLaboratory of Organic Chemistry, Gifu Pharmaceutical University 1-25-4 Daigaku-Nishi, Gifu 501-1196, Japan.ORCID 0000-0003-2792-6826
Taro MatsumotoDepartment of Functional Morphology, Division of Cell Regeneration and Transplantation, Nihon University School of Medicine, Tokyo 173-8610, Japan.ORCID 0000-0002-2965-2673
Hiroaki TokiwaLaboratory of Organic Chemistry, Gifu Pharmaceutical University 1-25-4 Daigaku-Nishi, Gifu 501-1196, Japan.ORCID 0000-0002-3790-1799
Makoto MakishimaDivision of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Itabashi-ku, Tokyo 173-8610, Japan.ORCID 0000-0002-4630-905X
Sachiko YamadaDivision of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Itabashi-ku, Tokyo 173-8610, Japan.
Nihon University · JPGifu Pharmaceutical University · JPRikkyo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The active form of vitamin D

Indexed as

CholecalciferolVitamin DCell DifferentiationGene Expression RegulationHumans1,25-dihydroxyvitamin DCholecalciferolVitamin Dcell selectivitynuclear receptorosteoblast differentiationvitamin D

Identifiers

PMID37509118
PMCPMC10377034
OpenAlexW4383553954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.